PR Biotech Nation with Moira Gunn
July 21, 2026
News & Publications
In The News
Cell & Gene with Erin Harris
July 9, 2026
BioWorld, In the Clinic
June 8, 2026
Investing.com – Editorial Staff
May 29, 2026
Gene Online – Editorial Staff
May 29, 2026
Press Releases
Diakonos Oncology Announces First Patients Dosed in Phase 1/2 DOC-RM Study of DOC1021 in Refractory Melanoma
July 30, 2026
Diakonos Oncology Shares Updated DOC1021 GBM Survival Data and Unveils Melanoma Clinical Study at ASCO 2026
June 5, 2026
Diakonos Oncology Awarded Fast Track Designation by FDA for DOC1021 (dubodencel) in Unresectable or Metastatic Cutaneous Melanoma
May 6, 2026
Diakonos Oncology to Present Corporate Overview and Participate in Panel at 2026 Biotech Showcase
December 15, 2025
Diakonos Oncology Awarded Multi-Million-Dollar Research Grant by the Cancer Prevention and Research Institute of Texas to Advance DOC1021 in Refractory Melanoma
December 10, 2025
Company Presentations
Diakonos Oncology to Present Corporate Overview and Participate in Panel at 2026 Biotech Showcase
December 15, 2025
Medical Digest SITC Interview – Phase I Trial of DOC1021 Cell-Based Immunotherapy for Resectable or Borderline Resectable Ductal Adenocarcinoma
November 27, 2025
Diakonos Oncology Presents Promising Phase I Results of Dubodencel (DOC1021) at the ASCO 2025 Annual Meeting
June 2, 2025
Diakonos Oncology Presents Phase I Analysis of DOC1021 at the 2025 American Academy of Neurology Annual Meeting
April 9, 2025
2025 Spring Symposium hosted by the William T. Shearer Center for Human Immunobiology
March 7, 2025
Publications
Science Translational Medicine: A Unique Subset of Cytotoxic Effector Memory T-cells Enhances CAR T-cell Function against Pancreatic Ductal Adenocarcinoma. Konduri V, Joseph S, Byrd TT, et al.
May 5, 2022
FASEB Journal: MHC class I and II peptide homology regulates the cellular immune response. FASEB. Halpert MM, Konduri V, Liang D, et al.
April 16, 2020
Cancer Gene Therapy: Dendritic cell vaccination plus low-dose Doxorubicin for the treatment of spontaneous canine hemangiosarcoma. Konduri V*, Halpert MM*, et al. Cancer Gene Therapy.
January 23, 2019
Frontiers in Immunology: AIMp1 Potentiates TH1 polarization and is critical for effective antitumor and antiviral immunity. Liang D, Tian L, You R, et al.
January 15, 2018
OncoImmunology: Chemo-immunotherapy mediates durable cure of orthotopic KrasG12D/p53-/- pancreatic ductal adenocarcinoma. Oncoimmunology. Konduri V, Li D, Halpert MM, et al.
July 22, 2016
Connect with us on social
